Skip to main content

Screening for Colon Polyps and Cancer

  • Chapter
  • First Online:
Epidemiologic Studies in Cancer Prevention and Screening

Part of the book series: Statistics for Biology and Health ((SBH,volume 79))

Abstract

Colorectal cancer (CRC) carries a significant health burden, accounting for 610,000 deaths worldwide in 2008. CRC is the fourth most common malignancy and the second leading cause of cancer-related death in the United States. Colon screening is arguably the greatest cancer prevention success story of the last 25 years contributing substantially to over a 40 % reduction in CRC mortality in the USA since 1975. Screening rates in the USA currently exceed 60 % and are steadily rising. Randomized screening trials have demonstrated a 33 % reduction in CRC mortality with the use of annual fecal occult blood testing (FOBT) and a 27–31 % reduction in CRC mortality with flexible sigmoidoscopy (FS). Despite this robust evidence for FOBT and FS, colonoscopy use has been on the rise in the USA and has emerged as the preferred colon screening modality. Colonoscopy has a conceptual advantage as it is the only single-step test that allows visualization of the entire colon and removal of polyps simultaneously. Retrospective data suggests that colonoscopy may not be as protective of colon cancer in the proximal colon; however, prospective data on the impact of colonoscopy screening on incidence and mortality is not yet available. Computerized tomography colonography (CTC) and fecal DNA testing are newer technologies that have a great deal of potential as screening modalities as technology advances. Although colon screening can be expensive depending on the test used, any type of screening appears to be cost-effective when taking into account the rising costs of CRC treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Ahlquist DA, Sargen DJ, Loprinzi CL, Levin TR, Douglas K. Rex DK, Ahnen DJ et al. Stool DNA and occult blood testing for screen detection of colorectal neoplasia. Ann Intern Med 2008;149:441–450.

    Google Scholar 

  • Allison JE, Sakoda LC, Levin TR, Tucker JP, Tekawa IS, Cuff T et al. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics. J Natl Cancer Inst 2007; 99:1462–1470.

    Article  Google Scholar 

  • Allison JE, Tekawa IS, Ransom LJ, Adrain AL. A comparison of fecal occult-blood tests for colorectal-cancer screening. N Engl J Med 1996; 334:155–160.

    Article  Google Scholar 

  • ASGE. Colorectal Cancer Screening and Surveillance. Gastrointestinal Endoscopy 2006; ­4:­546–557.

    Google Scholar 

  • Atkin WS, Edwards R, Kralj-Hans I, Wooldrage K, Hart AR, Northover JMA, et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet 2010; 375:1624–1634.

    Article  Google Scholar 

  • ACN (Australian Cancer Network Colorectal Cancer Guidelines Revision Committee). Guidelines for the Prevention, Early Detection and Management of Colorectal Cancer. The Cancer Council Australia and Australian Cancer Network, Sydney 2005.

    Google Scholar 

  • Baxter NN, Goldwasser MA, Paszat LF, Saskin R, Urbach DR, Rabeneck L. Association of colonoscopy and death from colon cancer. Ann Intern Med 2009; 150:1–8.

    Google Scholar 

  • Breen N, Wagener DK, Brown ML, Davis WW, Ballard-Barbash R. Progress in Cancer Screening Over a Decade: Results of Cancer Screening From the 1987, 1992, and 1998 National Health Interview Surveys. J Natl Cancer Inst 2001; 93:1704–1713.

    Article  Google Scholar 

  • Brenner H, Chang-Claude J, Seiler CM, Rickert A, Hoffmeister M. Protection from colorectal cancer after colonoscopy: a population-based, case-control study. Ann Intern Med. 2011;154(1):22–30.

    Google Scholar 

  • Brenner H, Hoffmeister M, Arndt V, Stegmaier C, Altenhofen L, Haug U. Protection from right- and left-sided colorectal neoplasms after colonoscopy: population-based study. J Natl Cancer Inst. 2010; 102:89–95.

    Article  Google Scholar 

  • Byers T, Levin B, Rothenberger D, Dodd GD, Smith RA. American Cancer Society Guidelines for Screening and Surveillance for Early Detection of Colorectal Polyps and Cancer: Update 1997. CA Cancer J Clin 1997; 47:154–160.

    Article  Google Scholar 

  • Center MM, Jemal A, Smith RA, Ward E. Worldwide variations in colorectal cancer. CA Cancer J Clin. 2009; 59:366–378.

    Article  Google Scholar 

  • Colorectal Cancer Facts and Figures 2008–2010. American Cancer Society. Retrieved 12/29/2011 from http://www.cancer.org/acs/groups/content/@nho/documents/document/f861708finalforwebpdf.pdf.

    Google Scholar 

  • Cotton PB, Durkalski VL, Pineau BC, Palesch YY, Mauldin PD, Hoffman B et al. Computed tomographic colonography (virtual colonoscopy): a multicenter comparison with standard colonoscopy for detection of colorectal neoplasia. JAMA 2004; 291:1713–1719.

    Article  Google Scholar 

  • Eddy D. ACS report on the cancer-related health checkup. CA Cancer J Clin. 1980;30:193–240.

    Google Scholar 

  • EU (European Guidelines for quality assurance in colorectal cancer screening and diagnosis, first ­edition). European Union Health Programme 2010.

    Google Scholar 

  • Fruton JS. Proteins, Enzymes, Genes: the Interplay of Chemistry and Biology. New Haven, Connecticut: Yale University 1999.

    Google Scholar 

  • Garg S, Ahnen DJ. Is computed tomographic colonography being held to a higher standard? Ann Intern Med. 2010; 152:178–181

    Google Scholar 

  • Hassan C, Zullo A, Laghi A, Reitano I, Taggi F, Cerro P et al. Colon cancer prevention in Italy: cost-effectiveness analysis with CT colonography and endoscopy. Dig Liver Dis 2007; ­39:242–250.

    Article  Google Scholar 

  • Hewitson P, Glasziou P, Watson E, Towler B, Irvig L. Cochran systematic review of colorectal cancer screening using the fecal occult blood test (Hemoccult): an update. Am J Gastroenterol 2008; 103:1541–1549.

    Article  Google Scholar 

  • Hixson LJ, Fennerty MB, Sampliner RE, Garewal HS. Prospective blinded trial of the c­olonoscopic missrate of large colorectal polyps. Gastrointestinal Endoscopy 1991; 37:125–127.

    Article  Google Scholar 

  • Hixson LJ, Fennerty MB, Sampliner RE, McGee D, Garewal H. Prospective study of the fr­equency and size distribution of polyps missed by colonoscopy. J Natl Cancer Inst. 1990; 82:­69–1772.

    Article  Google Scholar 

  • Hoff G, Grotmol T, Skovlund E, Bretthauer M. Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomized controlled trial. BMJ 2009; 338:b1846.

    Article  Google Scholar 

  • Hol L, van Leerdam ME, van Ballegooijen M, van Vuuren AJ, van Dekken H, Reijerink JCIY et al. Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Gut 2010a; 59:62–68.

    Article  Google Scholar 

  • Hol L, de Jonge V, van Leerdam ME, van Ballegooijen M, Looman CWM, van Vuuren AJ et al. Screening for colorectal cancer: Comparison of perceived test burden of guaiac-based faecal occult blood test, faecal immunochemical test and flexible sigmoidoscopy. Eur J Cancer 2010b; 46:2059–2066.

    Article  Google Scholar 

  • Hundt S, Haug U, Brenner H. Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection. Ann Intern Med 2009;150:162–169.

    Google Scholar 

  • Hur C, Chung DC, Schoen RE, Gazelle GS. The management of small polyps found by virtual colonoscopy: results of a decision analysis. Clin Gastroenterol Hepatol 2007; 5:237–244.

    Article  Google Scholar 

  • Imperiale TF, Wagner DR, Lin CY, Larkin GN, Rogge JD, Ransohoff DF. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med 2000; 343:169–174.

    Article  Google Scholar 

  • Imperiale TF, Ransohoff DF, Itzkowitz SH, Turnball BA, Ross ME. Fecal DNA versus Fecal Occult Blood for Colorectal Cancer Screening in an Average Risk Population. N Engl J Med 2004; 351:2704–2714.

    Article  Google Scholar 

  • Johnson CD, Chen MH, Toledano AY, Heiken JP, Dachman A, Kuo MD et al. Accuracy of CT colonography for detection of large adenomas and cancers. N Engl J Med 2008; 359:1207–1217.

    Article  Google Scholar 

  • Kronborg O, Jorgensen OD, Fenger C, Rasmussen M. Randomized study of biennial screening with a faecal occult blood test: results after nine screening rounds. Scand J Gastroenterol 2004; 39:846–851.

    Article  Google Scholar 

  • Ladabaum U, Song K, Fendrick AM. Colorectal neoplasia screening with virtual colonoscopy: when, at what cost, and with what national impact? Clin Gastroenterol Hepatol 2004; 2:554–563.

    Article  Google Scholar 

  • Lansdorp-Vogelaar I, van Ballegooijen M, Zauber AG, Boer R, Wilschut J, Habbema JD. At what costs will screening with CT colonography be competitive? A cost-effectiveness approach. Int J Cancer. 2009;124:1161–1168.

    Article  Google Scholar 

  • Levi Z, Rozen P, Hazazi R, Vilkin A, Waked A, Maoz E et al. A quantitative immunochemical fecal occult blood test for colorectal neoplasia. Ann Intern Med 2007; 146:244–255.

    Google Scholar 

  • Levin B, Lieberman DA, McFarland B, Smith RA, Brooks D, Andrews KS et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin 2008; 58:130–160.

    Article  Google Scholar 

  • Levin B, Murphy GP. Revision in American Society Recommendations for the Early Detection of Colorectal Cancer. CA Cancer J Clin 1992; 42:296–99.

    Article  Google Scholar 

  • Lindholm E, Brevinge H, Haglind E. Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer. Br J Surg 2008; 95:1029–1036.

    Article  Google Scholar 

  • Luo Z, Bradley CJ, Dahman BA, Gardiner JC. Colon cancer treatment costs for Medicare and dually eligible beneficiaries. Health Care Financing Review 2009; 31:35–50.

    Google Scholar 

  • Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, Mongin SJ et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000; 343:1603–1607.

    Article  Google Scholar 

  • Mandel JS, Church TR, Ederer F, Bond JH. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst. 1999; 91:434–7.

    Article  Google Scholar 

  • Massachusetts Medical Society. New England Surgical Society (digitized 2007). Boston medical and surgical journal. 1907; 157:170–74. Boston, Mass. Harvard University.

    Google Scholar 

  • Moayyedi P, Achkar E. Does fecal occult blood testing really reduce mortality? A reanalysis of systematic review data. Am J Gastroenterol. 2006; 101:380–384.

    Article  Google Scholar 

  • Müller AD, Sonnenberg A. Protection by endoscopy against death from colorectal cancer. A case-control study among veterans. Arch Intern Med 1995; 155:1741–1748.

    Google Scholar 

  • National Cancer Institute. Colon and Rectal Cancer. Retrieved 12/29/2011 from http://www.cancer.gov/cancertopics/types/colon-and-rectal.

    Google Scholar 

  • Natalin RA, Landman J. Where next for the endoscope? Nature Reviews Urology 2009; ­6:622–628.

    Article  Google Scholar 

  • Newcomb PA, Norfleet RG, Storer BE, Surawicz TS, Marcus PM. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 1992; 84:1572–1575.

    Article  Google Scholar 

  • Pickhardt PJ, Choi JR, Hwang I, Butler JA, Puckett ML, Hildebrandt HA et al. Computed ­tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults. N Engl J Med 2003; 349:2191–2200.

    Article  Google Scholar 

  • Pickhardt PJ, Hassan C, Laghi A, Zullo A, Kim DH, Iafrate F et al. Small and diminutive polyps detected at screening CT colonography: a decision analysis for referral to colonoscopy. Am J Roentgenol 2008; 190:136–144.

    Article  Google Scholar 

  • Pignone M, Campbell MK, Carr C, Phillips C. Meta-analysis of dietary restriction during fecal occult blood testing. Eff Clin Pract 2001; 4:150–156.

    Google Scholar 

  • Podolsky DK. Going the distance - the case for true colorectal cancer screening. N Engl J Med. 2000; 343:207208.

    Article  Google Scholar 

  • Rex DK, Cutler CS, Lemmel GT, Rahmani EY, Clark DW, Helper DJ et al. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology 1997; 112: 24–28.

    Article  Google Scholar 

  • Rex DK, Johnson DA, Anderson JC, Schoenfeld PS, Burke CA, Inadomi JM. American College of Gastroenterology Guidelines for Colorectal Cancer Screening 2008. American Journal of Gastroenterology 2009; 104:739–750.

    Article  Google Scholar 

  • Rockey DC, Paulson E, Niedzwiecki D, Davis W, Bosworth HB, Sanders L et al. Analysis of air contrast barium enema, computed tomographic colonography, and colonoscopy: prospective comparison. Lancet 2005; 365:305–311.

    Google Scholar 

  • Rockey DC. Computed Tomographic Colonography: Current Perspectives and Future Directions. Gastroenterology 2009; 137:7–17.

    Article  Google Scholar 

  • Scholefield JH, Moss S, Sufi F, Mangham CM, Hardcastle JD. Effect of faecal occult blood ­screening on mortality from colorectal cancer: results from a randomized controlled trial. Gut 2002; 50:840–844.

    Article  Google Scholar 

  • Selby JV, Friedman GD, Quesenberry CP Jr, Weiss NS. A case-control study of screening ­sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 1992; 326:653–657.

    Article  Google Scholar 

  • Shah JP, Hynan LS, Rockey DC. Management of small polyps detected by screening CT ­colonography: patient and physician preferences. Am J Med 2009; 122:687. E1-9.

    Google Scholar 

  • Smith RA, von Eschenbach AC, Wender R, Levin B, Byers T, Rothenberger D et al. American Cancer Society Guidelines for the Early Detection of Cancer: Update for early detection ­guidelines for Prostate, Colorectal and endometrial cancers. CA Cancer J Clin 2001; ­51:38–75.

    Article  Google Scholar 

  • Soetikno R, Kaltenbach T. High-quality CT Colonography can detect nonpolypoid colorectal ­neoplasm (NP-CRN)-science or rhetoric? Academic Radiology. 2010;17:1317–1318.

    Article  Google Scholar 

  • Surveillance Epidemiology End Result (SEER). National Cancer Institute. Retrieved 12/29/2011 from http://seer.cancer.gov/faststats/selections.php?series=cancer.

    Google Scholar 

  • Thiis-Evensen E, Hoff GS, Sauar J, Langmark F, Majak BM, Vatn MH. Population-based ­surveillance by colonoscopy: effect on the incidence of colorectal cancer. Telemark Polyp Study I. Scand J Gastroenterol 1999;34:414–420.

    Article  Google Scholar 

  • USPSTF. Guide to clinical preventive services (2 nd edition), Report of the U.S. Preventive Services Task Force. Department of Health and Human Services, Washington, DC 1995. Retrieved 12/29/2011 from http://odphp.osophs.dhhs.gov/pubs/guidecps/.

    Google Scholar 

  • USPSTF. Screening for colorectal cancer: Recommendation and Rationale. Ann Intern Med 2002; 137:129–131.

    Google Scholar 

  • USPSTF. Screening for Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med 2008; 149:627–38.

    Google Scholar 

  • Van Rijn JC, Reitsma, JB, Stoker, J, Bossuyt PM,van Deventer SJ,  Dekker E. Polyp miss rate determined by tandem colonoscopy: a systematic review. Am J Gastroenterol 2006; ­101:343–350.

    Article  Google Scholar 

  • Vijan S, Hwang I, Inadomi J, Wong RKH, Choi JR, Napierkowski J et al. The cost-effectiveness of CT colonography in screening for colorectal neoplasia. Am J Gastroenterology 2007; ­102:380–390.

    Article  Google Scholar 

  • Vital Signs: Colorectal Cancer Screening, Incidence, and Mortality --- United States, 2002–2010. Morbidity and Mortality Weekly Report (MMWR) Center for Disease Control and Prevention (CDCP). Retrieved 12/29/2011 from http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6026a4.htm.

    Google Scholar 

  • Von Karsa L, Anttila A, Ronco G, Ponti A, Malila N, Arbyn M, et al. Cancer screening in the European Union. Report on the implementation of the Council recommendation on cancer screening – First Report. Luxembourg: European Commission; 2008.

    Google Scholar 

  • Warren, JL, Klabunde, CN, Mariotto, AB, Meekins A, Topor M, Brown ML et al. Adverse events after outpatient colonoscopy in the Medicare population. Ann Intern Med 2009; 150:849–857.

    Google Scholar 

  • Whitlock EP, Lin JS, Liles E, Beil TL, Fu R. Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2008; 149:638–658.

    Google Scholar 

  • Williams CB, Macrae FA, Bartram CI. A Prospective Study of diagnostic methods in adenoma follow-up. Endoscopy 1982; 14:74–78.

    Article  Google Scholar 

  • Winawer SJ, Stewart ET, Zauber AG, Bond JH, Ansel H, Waye JD et al. A comparison of colonoscopy and double-contrast barium enema for surveillance after polypectomy. National Polyp Study Work Group. N Engl J Med 2000; 342:1766–1772.

    Google Scholar 

  • Winawer SJ, Flehinger BJ, Schottenfeld D, Miller DG. Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy. J Natl Cancer Inst 1993; 85:1311–1318.

    Article  Google Scholar 

  • WGO (World Gastroenterology Organization/International Digestive Cancer Alliance). Practice Guidelines: Colorectal cancer screening. 2007.

    Google Scholar 

  • Yee J, Rosen MP, Blake MA, Baker ME, Cash BD, Fidler JL et al. ACR Appropriateness Criteria® Colorectal cancer screening. [online publication]. Reston (VA): American College of Radiology (ACR); 2010.

    Google Scholar 

  • Zauber AG, Lansdorp-Vogelaar I, Knudsen AB, Wilschut J, van Ballegooijen M, Kuntz KM. Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force. Ann Intern Med. 2008; 149:659–669.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dennis J. Ahnen M.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Patel, S.G., Ahnen, D.J. (2013). Screening for Colon Polyps and Cancer. In: Miller, A. (eds) Epidemiologic Studies in Cancer Prevention and Screening. Statistics for Biology and Health, vol 79. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-5586-8_16

Download citation

Publish with us

Policies and ethics